×
About 8,809 results

ALLMedicine™ Immunoglobulins Center

Research & Reviews  4,361 results

Anti-contactin-associated protein-like 2 antibody-associated cerebellar ataxia: A case ...
https://doi.org/10.1016/j.jneuroim.2021.577515
Journal of Neuroimmunology; Wang J, Qiu Z et. al.

Feb 28th, 2021 - The spectrum of anti-contactin-associated protein-like 2 (CASPR2) antibody-associated disease is expanding and the involvement of cerebellum was reported in the past few years. We report a 45-year-old male with chronically progressive cerebellar a...

Identification Of Paraproteins Via Serum Immunofixation or Serum Immunosubtraction and ...
https://doi.org/10.5858/arpa.2020-0441-OA
Archives of Pathology & Laboratory Medicine; Mrosewski I, Urbank M

Feb 26th, 2021 - In laboratory testing for monoclonal gammopathies, paraproteins are identified via serum immunofixation or serum immunosubtraction and immunoturbidimetric quantitation of serum immunoglobulins is often used. To evaluate methodic differences betwee...

Altered immunoglobulin G glycosylation in patients with isolated hyperprolactinaemia.
https://doi.org/10.1371/journal.pone.0247805
PloS One; Hirschberg D, Ekman B et. al.

Feb 26th, 2021 - Prolactin is a peptide hormone produced in the anterior pituitary, which increase in several physiological and pathological situations. It is unclear if hyperprolactinaemia may affect glycosylation of immunoglobulin G (IgG). Twenty-five patients w...

Nonimmune antibody interactions of Group A Streptococcus M and M-like proteins.
https://doi.org/10.1371/journal.ppat.1009248
PLoS Pathogens; Mills JO, Ghosh P

Feb 25th, 2021 - M and M-like proteins are major virulence factors of the widespread and potentially deadly bacterial pathogen Streptococcus pyogenes. These proteins confer resistance against innate and adaptive immune responses by recruiting specific human protei...

see more →

Guidelines  1 results

Recommendations for the use of albumin and immunoglobulins.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719274
Blood Transfusion = Trasfusione Del Sangue; Liumbruno GM, Bennardello F et. al.

Aug 6th, 2009 - Recommendations for the use of albumin and immunoglobulins.|2009|Liumbruno GM,Bennardello F,Lattanzio A,Piccoli P,Rossettias G,|administration & dosage,adverse effects,blood,administration & dosage,adverse effects,analysis,

see more →

Drugs  3 results see all →

Clinicaltrials.gov  4,395 results

Anti-contactin-associated protein-like 2 antibody-associated cerebellar ataxia: A case ...
https://doi.org/10.1016/j.jneuroim.2021.577515
Journal of Neuroimmunology; Wang J, Qiu Z et. al.

Feb 28th, 2021 - The spectrum of anti-contactin-associated protein-like 2 (CASPR2) antibody-associated disease is expanding and the involvement of cerebellum was reported in the past few years. We report a 45-year-old male with chronically progressive cerebellar a...

Identification Of Paraproteins Via Serum Immunofixation or Serum Immunosubtraction and ...
https://doi.org/10.5858/arpa.2020-0441-OA
Archives of Pathology & Laboratory Medicine; Mrosewski I, Urbank M

Feb 26th, 2021 - In laboratory testing for monoclonal gammopathies, paraproteins are identified via serum immunofixation or serum immunosubtraction and immunoturbidimetric quantitation of serum immunoglobulins is often used. To evaluate methodic differences betwee...

Altered immunoglobulin G glycosylation in patients with isolated hyperprolactinaemia.
https://doi.org/10.1371/journal.pone.0247805
PloS One; Hirschberg D, Ekman B et. al.

Feb 26th, 2021 - Prolactin is a peptide hormone produced in the anterior pituitary, which increase in several physiological and pathological situations. It is unclear if hyperprolactinaemia may affect glycosylation of immunoglobulin G (IgG). Twenty-five patients w...

Nonimmune antibody interactions of Group A Streptococcus M and M-like proteins.
https://doi.org/10.1371/journal.ppat.1009248
PLoS Pathogens; Mills JO, Ghosh P

Feb 25th, 2021 - M and M-like proteins are major virulence factors of the widespread and potentially deadly bacterial pathogen Streptococcus pyogenes. These proteins confer resistance against innate and adaptive immune responses by recruiting specific human protei...

see more →

News  49 results

Steroid and Immunoglobulin Standard of Care for MIS-C
https://www.medscape.com/viewarticle/945543

Feb 8th, 2021 - The combination of methylprednisolone and intravenous immunoglobulins works better than intravenous immunoglobulins alone for multisystem inflammatory syndrome in children (MIS-C), researchers say. "I'm not sure it's the best treatment because we ...

Low IgA Levels Associated With Increased Infection Risk in SLE Patients
https://www.staging.medscape.com/viewarticle/939481

Oct 20th, 2020 - A new study of immunoglobulin levels in adult patients with systemic lupus erythematosus (SLE) has found that acquired low levels of IgA are associated with a higher risk of infection. To the knowledge of first author Ibrahim Almaghlouth, MD, of t...

FDA gives nod to earlier use of Nplate in adults with ITP
https://www.mdedge.com/jcomjournal/article/210407/bleeding-disorders/fda-gives-nod-earlier-use-nplate-adults-itp?channel=39313
Mary Ellen Schneider

Oct 18th, 2019 - Romiplostim (Nplate) earned a new indication from the Food and Drug Administration, allowing for earlier usage in adult patients with immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splen.

Meta-analysis: IVIG bests anti-D on platelet count in pediatric ITP
https://www.mdedge.com/hematology-oncology/article/193951/bleeding-disorders/meta-analysis-ivig-bests-anti-d-platelet-count?channel=39313
Will Pass

Feb 5th, 2019 - For patients with pediatric immune thrombocytopenia (ITP), treatment with intravenous immunoglobulins (IVIG) is more likely to raise platelet count in the short-term, compared with anti-D immunoglobulins (anti-D), according the authors of a recent.

FDA approves Nplate for pediatric ITP
https://www.mdedge.com/pediatrics/article/191277/bleeding-disorders/fda-approves-nplate-pediatric-itp
Laura Nikolaides

Dec 17th, 2018 - The Food and Drug Administration has approved romiplostim (Nplate) for pediatric patients aged 1 year and older who have had immune thrombocytopenia (ITP) for at least 6 months and have had an insufficient response to corticosteroids, immunoglobul.

see more →